Guided Therapeutics, Inc. filed its 10-K on Mar 30, 2022 for the period ending Dec 31, 2021. In this report its auditor, UHY LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0873 USD | -12.70% | -12.26% | -43.13% |
1st Jan change | Capi. | |
---|---|---|
-43.13% | 4.87M | |
+8.07% | 219B | |
+6.59% | 183B | |
+11.26% | 133B | |
+26.57% | 108B | |
+0.65% | 63.06B | |
+13.35% | 52.02B | |
-0.62% | 48.2B | |
-0.93% | 40.37B | |
+11.54% | 39.35B |
- Stock Market
- Equities
- GTHP Stock
- News Guided Therapeutics, Inc.
- Guided Therapeutics, Inc. Auditor Raises 'Going Concern' Doubt